Drug Type Small molecule drug |
Synonyms ALX 0646, ALX 646, ALX-646 + [1] |
Target |
Mechanism 5-HT1D receptor agonists(Serotonin 1d (5-HT1d) receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H27Cl2N3 |
InChIKeyTUGKEJSQBWUHDJ-UHFFFAOYSA-N |
CAS Registry251967-66-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Disorders | Phase 1 | GB | - | |
Migraine Disorders | Phase 1 | - | - |